Open AccessCLAG-M chemotherapy followed by umbilical cord blood stem cell transplantation for primary refractory acute myeloid leukaemia in a child: A case report
Author(s) -
Jie Huang,
Xiaoyun Yang,
Liucheng Rong,
Yue Xue,
Jun Zhu,
Yongjun Fang
Publication year - 2020
Publication title -
world journal of clinical cases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.368
H-Index - 10
ISSN - 2307-8960
DOI - 10.12998/wjcc.v8.i22.5603
Subject(s) - medicine , umbilical cord , stem cell , transplantation , refractory (planetary science) , chemotherapy , umbilical cord blood transplantation , hematopoietic stem cell transplantation , oncology , surgery , immunology , genetics , physics , astrobiology , biology
The prognosis of paediatric primary refractory/relapsed acute myeloid leukaemia (R/R AML) remains poor. Intensive therapy is typically used as salvage treatment for those with R/R AML. No data are currently available about the use of the CLAG-M protocol as salvage therapy in paediatric patients with R/R AML.